InvestorsHub Logo
Followers 0
Posts 10
Boards Moderated 0
Alias Born 06/18/2020

Re: None

Sunday, 06/28/2020 11:02:17 PM

Sunday, June 28, 2020 11:02:17 PM

Post# of 27112
Just a thought

I've been trying to connect the dots regarding 2 facts:

* AYT# had 1.4 M Healgen COVID-19 tests in their warehouse available for distribution on June 1.
* As of June 26th, ABMC had only shipped ~ 10% of that amount.

I posit that ABMC, due to their relatively weak financial standing, was unable to front the capital required to initially place a large order of tests from Healgen to stockpile and sell. This resulted in a slower than desired start to their distribution for 2 reasons:

1) they required customers to pay up front before ABMC placed an order with Healgen, resulting in a less efficient stream of smaller orders to Healgen that took longer to fulfil on a per unit basis
2) because ABMC did not have tests ready to ship, some prospective customers elected to procure tests elsewhere

Perhaps ABMC has found an avenue, through Sternberg, to provide the necessary capital for them to place large orders w/ Healgen without having customer's cash in hand. If that's the case, I would expect to see a serious escalation of their distribution efficiency.